FDA, NIH Aim to Push New Breakthroughs, but the Budget's Tight

How many times have you heard news of a scientific breakthrough -- a cure for Alzheimer's, for aging, for cancer -- and then never hear another word about it? Often, that's because even great leaps in biomedicine can hit hurdles: either science has outpaced regulations, or regulations haven't been taken into account in the first place.